Epidemiologic evaluation of heart failure and its impact on health costs;Valutazione epidemiologica dello scompenso cardiaco e sue implicazioni sulla spesa sanitaria

Minerva Cardioangiologica

Volumn 46, Issue 7-8, 1998, Pages 235-239

  Bilora, F ^a   Vettore, G ^b   Saccaro, G ^b   Barbata, A ^b   Dei Rossi, C ^b   Petrobelli, F ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b NONE

Author keywords

Congestive heart failure; Epidemiology; Health care costs

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPERTENSION; ITALY; LENGTH OF STAY; MALE; RISK FACTOR;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DIGITALIS GLYCOSIDES; FEMALE; HEALTH CARE COSTS; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; HYPERTENSION; ITALY; LENGTH OF STAY; MALE; RISK FACTORS;

EID: 0032107353     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention: Trends in ischemic hearts disease mortality United States, 1980-1988. MMWR 1992;41:548-9, 555-6.
2. Gillum RF. Trends in acute MI and coronary heart disease death in the United States. J Am Coll Cardiol 1994: 23:1273-7.
3. Yusuf S, Thom T, Abbott RD. Changes in hypertension treatment and in CHF mortality in United States. Hypertension 1989;13(Suppl 5): 174-9.
4. Cohn JN. Current therapy of the failing heart. Circulation 1988;78:1099-107.
5. Ghali JK, Cooper R, Ford E. Trends in hospitalisation rates for heart failure in United States. 1973-1986: evidence for increasing population prevalence. Arch Intern Med 1990;150:769-73.
6. American College of Cardiology/American Heart Association Commitee on Evaluation and Management of Heart Failure: Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995; 26:1376-98
7. Mc Govern PG, Pankow JS, Shahar E, Doliszky KM, Folsorm AR, Blackburn H et al. Recent trends in acute coronary heart disease. Mortality, morbility, medical care, risk factors. N Engl J Med 1996;334:884-90.
8. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure. The Framingham study. N Engl J Med 1971;285:1441-6.
9. Bonow RO, Udelson JE. Luft ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanism and management. Ann Intern Med 1992; 117:502-10.
10. Anderson B, Waagstein F. Spectrum and outcome of congestive Mean failure in a hospedalized population. Am Heart J 1987;113:1043-5.
11. Tsuyuki RT, Teo KK, Ikuta RM, Bay KS, Greenwood PV, Montagne TJ. Mortality risk and patterns of practice in 2070 patients with acute myocardial infarction, 1987-92. Chest 1994;105:1687-92.
12. Dittrich H, Giepin E, Nirod P, Cali G, Henning H. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1-7.
13. CONSENSUS trial study group: Effect of enalapril on mortality in severe heart failure: results of the co-operative survival study (CONSENSUS). N Engl J Med 1987; 316:1429-35.
14. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA et al. Beneficial effects of metoprolol in idiopathic cardiomyopathy. Lancet 1993;343: 1441-6.
15. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB et al. Carvedilol inhibits clinical progression in patients with mid heart failure. Circulation 1996;94:2800-7.
16. The digitalis investigation group: rationale design, implementation and baseline characteristics of patients in the DIG trial: a large, simple, long term trial to evaluate the effect of digitalis on mortality in heart failure. Controlled Clin Trials 1996;17:77-97.
17. Graves EJ. National hospital discharge survey: annual summary, 1988. Vital and health statistics. Series 13: Data from National Health Survey, 1995;121:1-63.
18. Veterans Administration cooperative study group on antihypertensive agents: effects of treatment on morbidity in hypertension.II. Results in patients with diastolic blood pressure averaging 90-115 mmHg. JAMA. 1970;213:1143-52.
19. Scandinavian Simvastatin Survival Study Group: baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 1995;345:1274-5.
20. Waagstein F, Hjalmarson A, Varnauskas E et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;137:1022-36
21. Kornowski R, Zeeli D, Averbuch M, Finkelstein A, Schwartz D, Moshkovitz M et al. Intensive home care serveillance prevents hospitalisation and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995;129:762-6.